Brain inflammation is associated with neurodegenerative diseases including Alzheimer's, Parkinson's
More than 90 professional football players have been diagnosed with CTE
Inflammation in the brain has been associated with neurodegernative diseases like Alzheimer’s and Parkinson’s, and a new study links it for the first time to chronic traumatic encephalopathy, or CTE.
The researchers compared the brains of 48 former football players diagnosed with CTE with the brains of 18 players who didn’t have the disease and those of 16 non-players. They found that those who had increased hits to the head, even though they hadn’t been diagnosed with CTE, had increased inflammation. That inflammation increased with a longer time playing football and with CTE severity.
What is CTE?
CTE is believed to be a result of repeated trauma to the head. More than 90 former professional football players who donated their brains for research have been diagnosed with the Alzheimer’s-like neurodegerative disease. Some of the best-known players diagnosed with CTE include Hall of Famer and San Diego Charger Junior Seau, who killed himself in May 2012 at the age of 43, and legendary sportscaster and Hall of Famer Frank Gifford, who died of natural causes in August 2015 at the age of 84.
Though it has similar symptoms to Alzheimer’s – including memory loss, mood swings and depression – it has a distinct pathology, with an abnormal protein called tau taking over specific regions of the brain.
A confirmed diagnosis cannot be made without an autopsy. However, recent research has looked into the use of MRI imaging and potential biomarkers to help detect the disease in the living.
Dr. Thor Stein, one of the authors of the new study, said that although it wasn’t surprising to see an increase in inflammation, it wasn’t clear exactly whether the inflammation was specifically causing the disease or was a reaction to it, but more likely, it was both.
Inflammation and the brain
Heather Snyder, senior associate director of medical and scientific relations for the Alzheimer’s Association, said researchers were still trying to understand the basic function of inflammation in the brain, let alone in disease. “It’s still an early study. There are a lot of unanswered questions. We’re just trying to understand the basic role in normal function.”
Though Snyder was not involved in the study, the Alzheimer’s Association did support Stein in this work.
The brain is a unique organ, said Stein, in that it has its own inflammatory cells that act as a monitoring system. “These inflammatory cells are constantly migrating through the brain. Then, if there’s an infection, they react quickly. Same with trauma: Inflammatory cells quickly migrate to the area of trauma and probably perform some protective mechanism.” But in some brains, these inflammatory cells don’t shut down, and inflammation persists.
Eventually, Stein hopes studies like this can help develop tools to determine the degree of injury to the brain and when it’s OK for players to return to the field. “The ultimate goal is to figure out which particularly inflammatory cells that are more problematic than others and then ultimately use drugs to prevent the disease.” But he cautioned that the study was still very early.
Join the conversation
Dr. Richard Isaacson, director of the Alzheimer’s Prevention Clinic at Weill Cornell Medicine and New York-Presbyterian, agreed but believes that this type of work was a step in the right direction. “We’re still a long way away for developing targeted treatments for different types of brain inflammation, and I think that’s the next frontier.”